Biofrontera earnings were -$11.1M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest BFRI earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$4.8M, down 184.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BFRI reported annual earnings of -$10.5M, with -40.7% growth. The next BFRI earnings date is Aug 12, 2026.
Biofrontera (NASDAQ: BFRI) reported Q1 2026 earnings per share (EPS) of -$0.41, up 12.77% year over year. Total BFRI earnings for the quarter were -$4.75 million. In the same quarter last year, Biofrontera's earnings per share (EPS) was -$0.47.
The next BFRI earnings date is Invalid Date. Add BFRI to your watchlist to be reminded of Biofrontera's next earnings date.
Is Biofrontera profitable or losing money?
As of the last Biofrontera earnings report, Biofrontera is currently losing money. Biofrontera's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$11.09 million, a 3.82% decrease year over year.
What was BFRI's earnings growth in the past year?
As of Biofrontera's earnings date in Q3 2026, Biofrontera's earnings has grown year over year. BFRI earnings in the past year totalled -$11.09 million.
What are Biofrontera's earnings expectations?
The current EPS estimate for Biofrontera's earnings report in Invalid Date is -$0.17.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.